therapeutic use

Psilocybin and MDMA — Therapeutic Use Permitted in Australia from July 1st 2023

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. Commonly found in tablet or crystal form, MDMA is a potent psychoactive drug with stimulant properties that produces experiences of empathy and sympathy. Both are currently prohibited in Australia, but will soon be available for therapeutic use. In so

psychedelics webinar recap

Psychedelics Webinar Recap

Last week, we presented a psychedelics webinar entitled “How to Protect Your Psychedelics Business.” The panelists were Paul Coble, me (Griffen Thorne from our Los Angeles office), and Graham Pechenik of Calyx Law in San Francisco. In the webinar, we presented on business law and intellectual property issues that will affect new psychedelics businesses in

psychedelics regulation

States are Missing Out on Psychedelics Regulation

In 2023, Oregon will have a regulated psilocybin market. Colorado voters will have a chance to vote on something similar this fall (although Initiative 58 would not take effect until 2024). Other than that, not a single other state has any form of psychedelic regulation in the works. Last week, an attempt to simply decriminalize

psychedelic drugs

Letter Shows Feds are Gearing Up for Psychedelic Drug Approvals

A recently published letter (“Letter”) indicates that the Biden administration is preparing for the approval of psychedelic drugs and MDMA to treat mental illness and PTSD. This type of federal agency correspondence would have been unimaginable five or six years ago. Things are changing fast! There are well-known potential health benefits of MDMA and psychedelics

dea psychedelics tryptamines

DEA Retreats on Five Psychedelic Compounds

Friday was a great day for psychedelics. More generally, Friday was a great day for science and medicine, the rule of law and rational inquiry. This is because the DEA backed down on its clumsy attempt to ban five more psychedelic substances (tryptamines), which it had moved to place on Schedule I of the federal

florida psychedelics

Florida Legislature May Need Psychedelics Advocate

Florida Rep. Michael Grieco’s decision not to seek a new legislative term could negatively impact efforts to advance the legal use of psychedelics in the Sunshine State. The representative has been the most vocal advocate for psychedelics reform in the Florida Legislature. In 2021, Grieco filed a bill (HB 549) that would have legalized the

california psychedelics update

California Psychedelics Update

I recently published a nationwide psychedelics law roundup post. But in doing so, I realized that it’s been a while since we did a comprehensive California psychedelics update. Today, I’ll walk through the two key proposed California psychedelics laws and where they stand. California’s push to decriminalize (almost) all psychedelics In 2021, California Senator Scott

u.s. immigration law psychedelics

Psychedelics and U.S. Immigration Law

The gap in the treatment of controlled substances between the state and federal levels continues to widen. That has long been true with cannabis, but the trend has accelerated with psilocybin and other psychedelics recently. This growing disparity has implications under U.S. immigration law for employers and non-residents who wish to become involved in the

dmt

DMT Therapy: Coming to a Clinic Near You?

DMT, or N, N-dimethyltryptamine is a powerful psychedelic. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back

Subscribe To Our Blog

Explore the latest legal news and insight regarding China, cannabis, international law, immigration, dispute resolution and Web3.